Published in Sci Rep on February 26, 2016
Regulation, Signaling, and Physiological Functions of G-Proteins. J Mol Biol (2016) 0.79
S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction. Cancers (Basel) (2016) 0.79
Biochemical, Biophysical and Cellular Techniques to Study the Guanine Nucleotide Exchange Factor, GIV/Girdin. Curr Protoc Chem Biol (2016) 0.75
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71
Cancer genome landscapes. Science (2013) 25.33
Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol (2008) 8.72
G-protein-coupled receptors and cancer. Nat Rev Cancer (2007) 6.80
Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. J Clin Oncol (2015) 5.48
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science (2014) 5.25
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell (2014) 4.44
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol (2013) 4.11
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol (2009) 3.14
MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med (2008) 3.00
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol (2009) 2.74
Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res (2013) 2.50
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer (2012) 2.49
Use of research biopsies in clinical trials: are risks and benefits adequately discussed? J Clin Oncol (2012) 2.43
Molecular biomarker analyses using circulating tumor cells. PLoS One (2010) 2.38
Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med (2014) 2.12
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer (2013) 2.05
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer (2006) 1.72
S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell (2011) 1.71
Cancer. Circulating tumor cells. Science (2013) 1.68
Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res (1997) 1.68
Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology (2002) 1.38
Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer (2013) 1.38
Clinical relevance and biology of circulating tumor cells. Breast Cancer Res (2011) 1.34
Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem (2012) 1.31
GIV/Girdin is a rheostat that fine-tunes growth factor signals during tumor progression. Cell Adh Migr (2011) 1.31
GIV/Girdin transmits signals from multiple receptors by triggering trimeric G protein activation. J Biol Chem (2015) 1.27
Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res (2012) 1.12
MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway. Oncotarget (2014) 1.10
Multiple molecular markers as predictors of colorectal cancer in patients with normal perioperative serum carcinoembryonic antigen levels. Clin Cancer Res (2007) 1.10
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients. Mol Oncol (2014) 1.05
Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer. Cancer Lett (2014) 1.05
Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel. Int J Oncol (2006) 1.04
MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway. PLoS One (2013) 1.02
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol (2012) 1.02
Overexpression of S100A4 is closely associated with progression of colorectal cancer. World J Gastroenterol (2005) 1.01
Nuclear S100A4 is a novel prognostic marker in colorectal cancer. Eur J Cancer (2010) 0.99
Molecular signature detection of circulating tumor cells using a panel of selected genes. Cancer Lett (2008) 0.97
Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer. Mol Oncol (2013) 0.92
Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis. Clin Chem (2014) 0.91
G Protein binding sites on Calnuc (nucleobindin 1) and NUCB2 (nucleobindin 2) define a new class of G(alpha)i-regulatory motifs. J Biol Chem (2011) 0.91
Circulating tumour cells: insights into tumour heterogeneity. J Intern Med (2013) 0.91
Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling. Elife (2015) 0.90
MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg (2013) 0.90
Molecular characterization of circulating tumor cells in human metastatic colorectal cancer. PLoS One (2012) 0.89
A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer. Int J Cancer (2014) 0.89
PIK3CA mutational status in circulating tumor cells can change during disease recurrence or progression in patients with breast cancer. Clin Cancer Res (2014) 0.89
G protein coupled growth factor receptor tyrosine kinase: no longer an oxymoron. Cell Cycle (2015) 0.86
A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer. J Cell Mol Med (2012) 0.85
Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time. Bioessays (2016) 0.85
MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET. Oncol Lett (2014) 0.84
KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer. PLoS One (2014) 0.84
Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients. Mol Oncol (2015) 0.83
Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer. Int J Gynecol Cancer (2015) 0.83
Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra. Aging (Albany NY) (2015) 0.82
Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion. Tumour Biol (2014) 0.82
Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. PLoS One (2015) 0.81
Importance of circulating tumor cells in newly diagnosed colorectal cancer. Int J Oncol (2015) 0.81
The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma. J Oral Pathol Med (2015) 0.80
Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells. Br J Cancer (1999) 0.80
Effects of MACC1 siRNA on biological behaviors of HeLa. Arch Gynecol Obstet (2013) 0.79
Silence of MACC1 expression by RNA interference inhibits proliferation, invasion and metastasis, and promotes apoptosis in U251 human malignant glioma cells. Mol Med Rep (2015) 0.78